Peptides are short chains of amino acids — typically 2 to 50 linked by peptide bonds. They act as precision signaling molecules: binding to specific cell receptors to trigger targeted biological responses without the broad effects of larger hormones or drugs.

Different peptides signal different functions. BPC-157 upregulates growth factors for tissue repair. CJC-1295 signals the pituitary to release growth hormone. Selank modulates GABA receptors to reduce anxiety. Each has a specific mechanism determined by its amino acid sequence.

Your body already produces thousands of peptides naturally — insulin, oxytocin, and endorphins are all peptides. Exogenous protocols supplement these existing pathways rather than introducing entirely foreign compounds.

Peptides are signaling molecules — they tell your body to produce more of its own hormones through natural feedback loops. Anabolic steroids are synthetic exogenous hormones — they bypass your body's production systems entirely.

For example, CJC-1295 + Ipamorelin stimulates your pituitary to release your own growth hormone in natural pulsatile patterns. Exogenous HGH injections flood the body with synthetic growth hormone, suppressing natural production over time.

The risk profiles are fundamentally different. Peptides generally maintain the body's feedback mechanisms. Steroids can suppress natural hormone production, requiring post-cycle therapy.

Legal status varies by country and specific peptide. In the US, most research peptides are legal to purchase as "research chemicals — not for human consumption." Some like semaglutide and tirzepatide are FDA-approved prescription medications.

Key distinctions: Prescription peptides (semaglutide, tirzepatide, sermorelin) require a doctor's prescription. Research peptides (BPC-157, TB-500, CJC-1295) are sold for research purposes. Most peptides are banned in sport by WADA.

Healing & Recovery: BPC-157, TB-500, GHK-Cu — accelerate tissue repair, reduce inflammation.

Growth Hormone Secretagogues: CJC-1295, Ipamorelin, Sermorelin, Tesamorelin, GHRP-2, GHRP-6, Hexarelin, MK-677 — stimulate natural GH release.

Cognitive Enhancement: Selank, Semax, PE-22-28, Dihexa, P21 — modulate neurotransmitters and neurotrophic factors.

Fat Loss & Metabolic: Semaglutide, Tirzepatide, Retatrutide, CagriSema, Fragment 176-191, AOD-9604, 5-Amino-1MQ, Tesofensine.

Longevity & Anti-Aging: Epithalon, FOXO4-DRI, MOTS-C, Humanin, SS-31, NAD+/NMN.

Immune & Gut Health: Thymosin Alpha-1, Thymalin, LL-37, KPV, VIP, Larazotide.

Sexual Health & Hormonal: PT-141, Melanotan II, Kisspeptin-10, Gonadorelin.

Lyophilized means freeze-dried. Most peptides arrive as a powder or "cake" in a sealed vial. Freeze-drying removes all water while preserving molecular structure, extending shelf life significantly.

Before use, lyophilized peptides must be reconstituted — adding bacteriostatic water to create an injectable solution. Once reconstituted, most remain stable for 28-30 days refrigerated.

Subcutaneous (SubQ) goes into the fat layer beneath the skin at a 45° angle using a 29-31 gauge insulin syringe. Common sites: abdomen, outer thigh, upper arm. Provides slower, sustained absorption. This is the standard route for most peptides.

Intramuscular (IM) goes directly into muscle tissue at 90° using a longer needle. Provides faster absorption. Used for specific peptides like Thymalin. Common sites: deltoid, outer thigh, hip.

Most peptides aren't effectively absorbed orally because digestive enzymes break down peptide bonds. Notable exceptions:

BPC-157 Oral — research suggests unique GI effects and systemic benefits via the gut-brain axis. The most common oral peptide.

MK-677 — orally bioavailable growth hormone secretagogue taken as capsule or liquid.

Semaglutide — available in both injectable (Ozempic) and oral (Rybelsus) forms.

Intranasal peptides — Selank and Semax are administered as nasal sprays, absorbing through nasal mucosa directly to the brain.

Immediate to hours: Selank/Semax (15-30 min), PT-141 (1-4 hours), DSIP (same night).

Days to 1-2 weeks: BPC-157/TB-500 (initial healing), CJC-1295+Ipamorelin (improved sleep), semaglutide (appetite reduction).

2-4 weeks: GH peptides (body composition), fat loss peptides (measurable weight loss), cognitive peptides (sustained benefits).

1-3 months: Epithalon (telomere effects), longevity peptides (biomarker improvements), full healing outcomes.

Subjective effects (sleep, mood, energy) appear first; measurable changes (body composition, blood markers) take longer.

Yes. Common across many peptides: injection site reactions, water retention, headache, fatigue — mostly mild and transient.

GH peptides: water retention, numbness/tingling, increased appetite (especially MK-677), potential blood sugar elevation.

GLP-1 agonists: nausea, vomiting, diarrhea, constipation — especially during dose titration. Usually diminish over time.

Healing peptides: generally very well-tolerated. Occasional mild dizziness or nausea.

Research peptides are synthesized for laboratory use, sold as "not for human consumption" without FDA oversight. Quality varies widely — third-party testing (COA) is critical.

Pharmaceutical grade peptides are manufactured under GMP standards with rigorous quality control. FDA-approved peptides like semaglutide (Ozempic/Wegovy) are pharmaceutical grade.

The practical difference: purity verification. Always demand batch-specific COA showing HPLC purity ≥98%, mass spectrometry confirmation, and endotoxin testing.

Unreconstituted (lyophilized): Room temp for 1-3 months. Refrigerated (36-46°F) for 6-12+ months. Frozen for 1-2+ years (avoid freeze-thaw cycles).

Reconstituted (BAC water): Must be refrigerated. Use within 28-30 days. BPC-157 and DSIP are light-sensitive — store in dark area or wrap the vial.

Critical rules: Never freeze reconstituted peptides. Keep vials upright. When traveling, use insulated cooler with cold packs.

A COA verifies the identity, purity, and safety of a peptide batch. It's the single most important quality indicator:

HPLC Purity: Minimum 95%, ideally ≥98%. Separates and quantifies the peptide vs. impurities.

Mass Spectrometry: Confirms correct molecular weight within ±1 Da, verifying identity.

Endotoxin Testing (LAL): Must be <5 EU/mg. Critical for injectables.

Batch-Specific: Must reference the specific lot number matching your vial. Generic COAs are a red flag.

Third-Party Testing: The gold standard — independent labs like Janoshik or Colmaric Analyticals.

1. Wash hands. Clean surface. 2. Swab both vial tops with 70% alcohol. Let dry 10 sec. 3. Draw desired BAC water into insulin syringe (common: 1mL, 2mL, 2.5mL, 5mL). 4. Insert needle through peptide vial stopper. 5. Inject BAC water slowly down the inside wall — never directly on powder. 6. Remove syringe. Never shake. Gently swirl. 7. Solution should be clear and colorless (GHK-Cu is blue-green, normal). 8. Label: peptide name, concentration, date, expiration (28-30 days). 9. Refrigerate immediately.

Formula: Concentration (mcg/unit) = Total Peptide (mcg) ÷ Total Units of BAC Water. Standard 1mL insulin syringe = 100 units.

Example 1: 5mg BPC-157 + 2mL BAC → 5,000mcg ÷ 200 units = 25mcg/unit. For 250mcg dose: 250 ÷ 25 = 10 units.

Example 2: 2mg CJC-1295 + 2mL BAC → 2,000mcg ÷ 200 units = 10mcg/unit. For 100mcg dose: 100 ÷ 10 = 10 units.

Example 3: 10mg Epithalon + 2mL BAC → 10,000mcg ÷ 200 units = 50mcg/unit. For 5mg dose: 5,000 ÷ 50 = 100 units.

BAC water is sterile water with 0.9% benzyl alcohol preservative. The benzyl alcohol inhibits microbial growth — critical because you're piercing the rubber stopper multiple times over weeks.

Without preservative, bacteria can colonize within 24-48 hours. BAC water extends usable life to 28-30 days refrigerated.

Use BAC water for multi-dose vials (standard). Only use plain sterile water if using the entire vial in one dose within 24 hours.

1mL / 100-unit: Most versatile. Works for reconstitution and injection. Each tick = 1 unit.

0.5mL / 50-unit: Better for small doses. Markings more spread out, easier to read at low volumes.

0.3mL / 30-unit: Maximum precision for micro-dosing (under 10 units).

29-31 gauge is standard. 31-gauge is nearly painless. Optional: 18-gauge drawing needle for easier BAC water withdrawal, then switch to insulin syringe.

2mL is the most common — creates easy-to-calculate concentrations with small injection volumes.

Use less water (1mL) for higher concentration / smaller volumes. Use more water (3-5mL) for lower concentration / easier measurement of very small doses.

The peptide doesn't care how much water — you inject the same total mcg regardless. The difference is injection volume per dose.

Abdomen: Most common. 1-2 inches from navel, in the "love handle" zone. Good fat layer, consistent absorption.

Outer thigh: Lateral quadriceps. Useful for rotation.

Upper arm: Tricep area. Slightly more awkward to self-inject but works for rotation.

Rotation is critical: Never inject the same exact spot repeatedly. Rotate 3-4+ sites to prevent lipodystrophy.

Before bed (GH peptides): CJC-1295, Ipamorelin, GHRP-2/6, Hexarelin. Amplifies natural nocturnal GH surge. 30-60 min before sleep, fasted 2+ hours.

Morning (cognitive): Selank, Semax, PE-22-28, Dihexa. Nootropic effects complement daytime activity.

Morning, fasted (fat loss): Fragment 176-191, AOD-9604. Most effective in fasted state.

Twice daily (healing): BPC-157, TB-500. AM and PM, often near injury site.

Yes, commonly done to reduce daily injections. Compatible combinations: CJC-1295 + Ipamorelin (classic GH stack), BPC-157 + TB-500 (healing stack).

Never mix in the same vial for storage — only combine in the syringe immediately before injection. Draw from separate vials to preserve stability.

Three likely causes: 1) BAC water sprayed too forcefully onto the powder (should go down the wall). 2) Vial was shaken instead of gently swirled. 3) Contamination or degradation from improper storage.

Rule: If it's cloudy, don't use it. Properly reconstituted peptides are clear and colorless (exception: GHK-Cu is blue-green due to copper).

With BAC water, refrigerated: 28-30 days for most peptides. DSIP: 14-21 days. With plain sterile water: 24-48 hours.

Signs of degradation: cloudiness, particles, color change, unusual smell. When in doubt, throw it out.

BPC-157 is a 15-amino-acid peptide from human gastric juice. Research suggests it accelerates healing of tendons, ligaments, muscles, bones, and GI tract by upregulating VEGF, promoting angiogenesis, and modulating nitric oxide pathways.

Studies indicate neuroprotective properties, gut healing benefits, and ability to counteract NSAID/alcohol damage. Research dosage: 250-500mcg 1-2x daily SubQ, often near the injury site. Also available orally for GI applications.

TB-500 is a synthetic version of Thymosin Beta-4 that promotes healing by upregulating actin — a cell-building protein for cell migration to injury sites. BPC-157 works through local growth factors; TB-500 has more systemic distribution.

TB-500 excels at promoting flexibility and reducing scar tissue. Typically 2-2.5mg 2-3x/week during loading, then reduced for maintenance.

Frequently stacked together (the "Wolverine Stack") because their mechanisms are complementary.

GHK-Cu (copper peptide) is a naturally occurring tripeptide. Blood levels decline significantly with age. Research suggests wound healing, collagen/elastin stimulation, anti-inflammatory, antioxidant, and gene-regulating properties.

Can be used topically (skin rejuvenation) and via SubQ injection (systemic anti-aging, typically 200mcg daily). Blue-green color when reconstituted is normal (copper ion).

Many practitioners recommend injecting as close to the injury as practical for localized conditions, since BPC-157 upregulates local growth factors.

However, BPC-157 also has systemic distribution — studies show effects even when injected distantly. For gut issues, oral BPC-157 may be equally effective. For a knee injury, inject near the knee. For systemic use, abdominal injection is standard.

BPC-157: 250mcg 2x/day (AM + PM), SubQ near injury. TB-500: 2.5mg 2x/week SubQ, loading 4-6 weeks, then 2.5mg 1x/week maintenance. Optional GHK-Cu: 200mcg/day for collagen support.

Duration: 4-8 weeks depending on injury severity. Many report improvement within 1-2 weeks for acute injuries.

Animal research shows strong evidence for GI protection and healing — gastric ulcers, inflammatory bowel conditions, NSAID-induced damage, and gut barrier integrity.

For GI applications, oral BPC-157 may be preferred (250-500mcg on empty stomach). Sometimes combined with Larazotide (tight junction regulator) and KPV (anti-inflammatory) for comprehensive gut healing.

LL-37 is a 37-amino-acid antimicrobial peptide from the cathelicidin family — your innate immune defense. Research suggests direct antimicrobial activity against bacteria, viruses, and fungi, plus immunomodulatory effects.

Used alongside healing peptides when infection risk, chronic biofilms, or immune support is needed. Research: 50-100mcg daily SubQ. Also studied for chronic wound healing.

Acute injuries: 4-6 weeks. Moderate injuries: 6-8 weeks, up to 12 for significant damage. Chronic conditions: 8-12+ weeks with potential maintenance phase.

Key principle: Don't stop when you feel better. Continue 2-4 weeks after symptoms resolve for complete structural healing.

Commonly combined. Peptides accelerate the biological healing process; PT provides the mechanical stimulus for tissue remodeling. Complementary modalities: red light therapy, contrast therapy, soft tissue work.

Peptides don't replace rehab — they potentially accelerate the timeline within which rehab produces results.

BPC-157 + NSAIDs: Research suggests BPC-157 may protect against NSAID-induced GI damage. Blood thinners: Caution warranted since BPC-157/TB-500 promote angiogenesis. Cancer history: Any growth-factor-upregulating peptide should be approached with caution.

CJC-1295 (without DAC) is a GHRH analog that tells the pituitary "time to release GH." Ipamorelin is a GHRP that triggers GH release through the ghrelin/GHS receptor — a separate pathway.

Combined: synergistic amplification. CJC-1295 primes; Ipamorelin triggers. Stronger, more physiological GH pulse than either alone, with fewer side effects than GHRP-6 or Hexarelin.

Common protocol: 100mcg CJC-1295 + 100mcg Ipamorelin SubQ before bed, fasted 2+ hours. Many run 5 days on / 2 off.

Without DAC (Mod GRF 1-29): ~30 min half-life. Sharp GH pulse mimicking natural physiology. Preferred for most protocols.

With DAC: 6-8+ day half-life. Sustained, elevated GH rather than pulses. More side effects (water retention, blood sugar).

Most practitioners prefer without DAC: better physiology, more effective for fat loss/recovery, pairs better with Ipamorelin.

Technically not a peptide — it's a non-peptide ghrelin receptor agonist. Grouped with GH peptides because it serves the same function. Major advantage: oral bioavailability (capsule or liquid). Long half-life (~24 hours).

Dose: 12.5-25mg daily. Key side effects: significant appetite increase, water retention, potential blood sugar elevation. Monitor fasting glucose, HbA1c, and insulin regularly.

Sermorelin is a 29-amino-acid GHRH analog used clinically since the 1990s. Shorter half-life (10-20 min) than CJC-1295 (~30 min). CJC-1295 was developed as an improved version with better enzymatic resistance.

Sermorelin's advantage: more clinical data, physician familiarity, easier to obtain through legitimate medical channels. Many anti-aging clinics prescribe it as a starting point.

Tesamorelin (Egrifta) is FDA-approved for reducing abdominal lipodystrophy in HIV patients — the only GH secretagogue with specific FDA fat-reduction approval.

Studies: reduces visceral fat by ~15-18% while preserving lean mass. Also improves IGF-1 and shows cognitive benefits. Dose: 1-2mg daily SubQ. Available through specialty pharmacies.

Elevated blood sugar and insulin directly suppress GH release. Eating raises glucose → insulin rises → GH output drops. This is normal physiology.

Optimal: Inject before bed, 2-3+ hours after last meal. The fasted state ensures low insulin. Avoid carb-heavy meals before your injection window.

Commonly reported: improved sleep quality (often first effect within a week), enhanced recovery, improved body composition, better skin/hair/nails, increased energy, and cognitive clarity.

GH naturally declines ~14% per decade after age 30. Results vary individually, are dose-dependent, and require consistent use. GH peptides work best with proper sleep, nutrition, and exercise.

GHRH analogs (CJC-1295, Sermorelin, Tesamorelin) = the "amplifier" — increase magnitude of each GH pulse.

GHRPs (Ipamorelin, GHRP-2, GHRP-6, Hexarelin) = the "trigger" — initiate a GH pulse through the ghrelin receptor.

One GHRH + one GHRP = synergistic amplification. CJC-1295 + Ipamorelin is the gold standard.

Primary marker: IGF-1. GH stimulates liver to produce IGF-1. Get baseline, retest at 6-8 weeks.

Also track: fasting glucose/insulin, HbA1c, metabolic panel, lipid panel. Target IGF-1: upper third of age-adjusted reference range. Above range = reduce dose.

Cycling prevents receptor desensitization. Common patterns:

5 on / 2 off: Use 5 days/week, 2 days off. Most popular for CJC-1295 + Ipamorelin.

3 months on / 1 month off: Macro-cycle for full resensitization.

Regular blood work (IGF-1, glucose) every 90 days confirms ongoing effectiveness.

Selank is a synthetic analog of tuftsin, developed in Russia and approved there as an anti-anxiety medication. It modulates GABAergic neurotransmission — like a sound engineer adjusting the calming system rather than flooding it like benzodiazepines.

Research: increases BDNF, enhances serotonin metabolism, anxiolytic effects without sedation. Typical: 250-500mcg intranasal 1-2x daily. Effects within 15-30 minutes.

Semax is a synthetic ACTH(4-7) analog. Selank = anxiolytic (calming focus). Semax = stimulatory (alertness, motivation). Increases BDNF, modulates dopamine/serotonin.

Dose: 200-600mcg intranasal 1-2x daily, morning/early afternoon (stimulatory). Often stacked: Selank (calm) + Semax (energy) + PE-22-28 (neurotrophic) = "The Limitless Stack."

Dihexa is described as potentially 10 million times more potent than BDNF at promoting synapse formation. Works through HGF/c-Met receptor pathway, distinct from other nootropics.

Research: 5-20mg orally or SubQ. One of the most experimental cognitive peptides — long-term human safety data is essentially nonexistent.

PE-22-28 (Spadin analog) is a TREK-1 potassium channel blocker. By blocking this channel, it enhances neurotransmission, increases BDNF, and produces antidepressant-like effects in animal models.

Included in cognitive stacks for the neurotrophic layer — supporting neuron growth/connectivity. Research: ~100mcg daily SubQ.

P21 is modeled after Ciliary Neurotrophic Factor (CNTF). Research suggests it promotes neurogenesis (new neurons in the hippocampus), reduces neuroinflammation, and may counteract tau pathology.

Interesting dual effect: also has appetite-suppressing properties through CNTF-like activity — relevant to both cognitive and weight management protocols.

Clear nose gently. Tilt head slightly forward (not back). Insert spray nozzle just inside nostril. Spray while gently inhaling. Alternate nostrils. Avoid aggressive sniffing — gentle inhalation keeps solution on nasal mucosa rather than draining to throat.

Each spray delivers a calibrated volume (typically 0.1mL). Concentration determines mcg per spray.

Common combinations: Selank/Semax + Lion's Mane (NGF support), alpha-GPC (acetylcholine), omega-3s (neuronal membranes), magnesium L-threonate (brain-penetrant Mg).

Caution: Semax is stimulatory — combining with high-dose caffeine or modafinil may cause overstimulation. Introduce one compound at a time.

DSIP (Delta Sleep Inducing Peptide) promotes delta wave sleep — the deepest, most restorative phase. Rather than forcing sedation, it appears to normalize sleep architecture.

Research: ~100mcg SubQ before bed. Light-sensitive — protect from light. Shorter shelf life (14-21 days reconstituted).

Semaglutide is a GLP-1 receptor agonist mimicking the incretin hormone GLP-1. Reduces hunger, slows gastric emptying, improves insulin sensitivity, reduces food reward signaling.

FDA-approved as Ozempic (diabetes) and Wegovy (weight). Clinical trials: ~15-17% body weight loss over 68 weeks. Once-weekly SubQ injection with dose titration from 0.25mg.

Tirzepatide is a dual GIP/GLP-1 receptor agonist. FDA-approved as Mounjaro (diabetes) and Zepbound (weight).

Clinical trials: ~20-26% body weight loss — significantly exceeding semaglutide. Once-weekly SubQ, 2.5mg up to 15mg. Some report better tolerability.

Retatrutide activates GLP-1, GIP, and glucagon receptors simultaneously. Glucagon promotes hepatic fat oxidation and increases energy expenditure — adding a metabolic dimension beyond appetite suppression.

Phase 2 results: up to 24% body weight loss at 48 weeks. Still in clinical trials as of 2026, not yet FDA-approved.

Fragment 176-191 is the fat-burning portion of growth hormone (amino acids 176-191) without growth-promoting or blood sugar effects. Stimulates lipolysis and inhibits lipogenesis.

Protocol: 250mcg 2x daily SubQ, fasted. Morning and before bed. Sometimes combined with AOD-9604.

5-Amino-1MQ is an NNMT inhibitor. NNMT is overexpressed in fat tissue during obesity — a metabolic brake. By inhibiting it, 5-Amino-1MQ may increase NAD+ in fat cells and promote conversion of white fat to metabolically active beige/brown fat.

Taken orally (50-100mg, 1-3x daily). Relatively newer compound; human clinical data still limited.

Tesofensine is a triple monoamine reuptake inhibitor (serotonin, dopamine, norepinephrine). Phase 2 trials: up to 12.8% body weight loss over 24 weeks through appetite suppression and thermogenesis.

Dose: 0.25-0.5mg oral daily. Side effects: elevated heart rate, insomnia, dry mouth. Not for cardiovascular conditions or anxiety disorders.

CagriSema combines cagrilintide (amylin analog) + semaglutide (GLP-1). Two complementary appetite pathways for enhanced efficacy. Phase 3 results compete with retatrutide.

Represents the trend toward multi-receptor combinations rather than single-target approaches. Progressing through regulatory review as of 2026.

Research shows ~two-thirds of lost weight returns within one year of stopping. Appetite returns to baseline without ongoing suppression.

Strategies: gradually taper rather than stopping abruptly, build sustainable habits during treatment, consider lower maintenance dose, use the treatment window to establish muscle mass and metabolic flexibility.

Up to 25-40% of weight lost may be lean tissue. Critical interventions: resistance training (2-3x/week minimum), high protein (1.0-1.2g per pound lean mass), creatine (5g daily), and optimized vitamin D/Mg/amino acids.

Some combine GLP-1s with GH peptides (CJC-1295+Ipamorelin) for lean mass preservation during aggressive fat loss.

AOD-9604 is a modified Fragment 176-191 with added tyrosine for improved stability. Received GRAS status from FDA as a food supplement (unusual for a peptide).

Research: 250-500mcg daily SubQ, fasted. Sometimes stacked with GH peptides for enhanced fat loss.

Epithalon is a synthetic pineal gland peptide. Primary mechanism: telomerase activation — stimulating the enzyme that adds protective DNA caps to chromosomes.

Telomeres shorten with each cell division → cellular senescence. Epithalon research (Dr. Khavinson): increased telomerase activity, improved aging biomarkers, melatonin restoration.

Protocol: 5-10mg daily SubQ for 10-20 day cycles, 2-3x per year.

Senolytics destroy senescent "zombie cells" that accumulate with age and secrete inflammatory factors (SASP) damaging surrounding tissue.

FOXO4-DRI disrupts the FOXO4-p53 interaction in senescent cells, releasing p53 to trigger apoptosis specifically in senescent cells while leaving healthy cells alone. Cutting-edge longevity research.

MOTS-C: Mitochondria-derived peptide. Activates AMPK, improves insulin sensitivity, promotes fat oxidation. Called "the exercise mimetic peptide."

SS-31 (Elamipretide): Binds cardiolipin in the inner mitochondrial membrane, optimizing electron transport chain efficiency and reducing oxidative stress at the source.

Together they address the mitochondrial hallmark of aging — dysfunction that's a primary driver of age-related decline.

Short peptides (2-4 amino acids) developed by Prof. Khavinson, each derived from specific organ tissue. Key bioregulators: Epitalon (pineal), Thymalin (thymus), Vilon (immune), Livagen (liver), Cortagen (brain), Vesugen (vascular).

Used in Russia/Europe for bioregulation therapy. Decades of research suggest they normalize organ function and potentially reverse age-related decline.

NAD+ is a coenzyme in every cell — essential for energy production, DNA repair, and sirtuin activation. Levels decline ~50% between ages 40-60.

Boosting approaches: NMN (250-1000mg oral daily), NR (another oral precursor), NAD+ IV (250-500mg infusion), NAD+ SubQ (at-home injection).

Foundational longevity intervention supporting virtually all other protocols. Stacks with Epithalon, MOTS-C/SS-31, and GH peptides.

Humanin is a 24-amino-acid mitochondria-derived peptide. Discovered protecting neuronal cells against Alzheimer's toxicity. Broader research: improves insulin sensitivity, reduces inflammation, protects against ischemic damage.

Circulating Humanin declines with age. Part of the growing class of mitochondria-derived peptides highlighting mitochondrial health's central role in longevity.

Telomeres: Epithalon (cyclical 10-20 day protocols). Senescent cells: FOXO4-DRI (research stage). Mitochondria: MOTS-C + SS-31 + NAD+/NMN. GH optimization: CJC-1295 + Ipamorelin (nightly). Tissue repair: GHK-Cu. Immune: Thymosin Alpha-1 or Thymalin.

Most people run subsets based on priorities, budget, and comfort level.

Epigenetic clocks (DNA methylation): TruAge, GrimAge — gold standard. Telomere length testing. Glycan age (GlycanAge). Functional biomarkers (composite blood work scores).

Test at baseline, re-test every 6-12 months to assess if interventions are working.

Tα1 is a 28-amino-acid thymus peptide. FDA-approved as Zadaxin in 35+ countries. Enhances T-cell maturation, modulates dendritic cells, balances Th1/Th2 immune responses.

Dose: 1.6mg SubQ 2-3x/week. Well-studied with a strong safety profile across decades of clinical use.

KPV is a tripeptide (Lys-Pro-Val) from alpha-MSH. Despite its tiny size, it inhibits NF-κB — a master inflammatory regulator. Can be administered orally and maintains GI effectiveness.

Often stacked with BPC-157 (oral) + Larazotide for comprehensive gut healing.

Larazotide regulates tight junctions by modulating zonulin signaling. Reached Phase 3 trials for celiac disease — the most advanced gut barrier peptide.

Cornerstone of gut healing stacks: Larazotide (barrier) + BPC-157 (tissue repair) + KPV (anti-inflammatory).

VIP has wide-ranging gut, brain, and immune effects. Primarily researched for CIRS (mold illness/biotoxin conditions) where VIP levels are depleted.

Administered as nasal spray, 50mcg multiple times daily. Most relevant for chronic inflammatory conditions rather than general biohacking.

Thymalin is a dipeptide bioregulator (Glu-Trp) from Khavinson's lab. Much smaller than the 28-amino-acid Tα1. Works through bioregulatory gene expression in the thymus.

Protocol: 10mg IM daily for 10 days, 1-2x/year. Positioned as a periodic immune "reset" rather than daily therapy.

Thymosin Alpha-1 — 1.6mg 2x/week (T-cell function). LL-37 — 100mcg daily (antimicrobial defense). Thymalin — 10mg daily IM for 10-day course, 1-2x/year (thymus restoration).

Addresses adaptive immunity, innate immunity, and immune organ restoration simultaneously.

Red light therapy (photobiomodulation) uses specific wavelengths to stimulate cellular function. Photons are absorbed by cytochrome c oxidase in mitochondria, releasing nitric oxide and boosting ATP production.

Primary wavelengths: 660nm (red) — 8-10mm penetration for skin/surface. 850nm (near-infrared) — up to 50mm for muscles, joints, organs.

Dosing: 10-40 J/cm² per area. Typical sessions: skin 5-15 min, deeper tissue 10-20 min, general wellness 10-15 min.

There's a biphasic dose response — too little has no effect, optimal range produces benefits, too much inhibits. More is not always better.

Wavelengths: Must include 660nm + 850nm. Irradiance: ≥100 mW/cm² at 6 inches. EMF: Low/zero at treatment distance. Third-party testing for wavelength/irradiance verification.

Mid-size panel (~24"×12") covering the torso is the best value starting point for most biohackers.

Complementary mechanisms: BPC-157 upregulates growth factors; RLT increases ATP and blood flow. Together, tissue receives enhanced signaling AND the energy/blood supply to act on it.

Practical: Apply RLT for 10-15 min to injury area, then inject BPC-157 nearby. Popular for tendon/joint rehab and post-surgical recovery.

Preliminary research suggests NIR light exposure to the testes may increase testosterone by enhancing mitochondrial function in Leydig cells. Small study showed increased levels.

This is still emerging with limited human data — more speculative than established applications like wound healing and pain reduction.

Strong evidence: Wound healing, pain reduction, skin health, inflammation reduction.

Moderate evidence: Exercise recovery, oral health, hair regrowth, cognitive improvement.

Preliminary/hyped: Testosterone enhancement, significant fat loss, dramatic anti-aging. RLT is legitimate but not a miracle cure.

Norepinephrine: 200-300% increase (focus, mood, energy). Brown fat activation (metabolic health). Inflammation reduction. Immune modulation. Dopamine elevation (sustained hours post-exposure).

The norepinephrine response occurs even at moderately cold temperatures (50-59°F).

Beginner: Cold showers, 30-60 sec coldest setting. Intermediate: 50-59°F plunge for 1-3 min. Advanced: 40-50°F for 2-5 min. Expert: Sub-40°F for 1-3 min.

Framework: 11 minutes total per week, spread across 2-4 sessions. Cold enough to want to get out but safe enough to stay in.

GH release: Single session = 200-300% increase; multi-round = up to 1600%. Cardiovascular: 4-7x/week users had 40% lower all-cause mortality in Finnish studies. Heat shock proteins. Detoxification. Endurance improvement.

Two 20-min sessions at 176°F+, separated by 30-min cool-down. Fasted state for maximum effect.

Can produce up to 1600% GH increase. Stack with CJC-1295+Ipamorelin before bed for maximum daily GH output.

Alternating heat (sauna) and cold (plunge). Creates a "vascular pump" — vasodilation → vasoconstriction cycling enhances circulation and metabolic waste clearance.

Protocol: 10-20 min sauna → 1-3 min cold → 2-4 rounds. End cold for alertness, hot for relaxation. Wait 4+ hours after strength training.

Traditional Finnish: 150-195°F. Most studied. Best for cardiovascular and GH protocols.

Far infrared: 120-150°F. Lower temp, better tolerated. Potentially superior for detox. Most popular for home use.

Near-infrared: Combines heat with photobiomodulation. Less studied. Steam room: Different experience, less studied for biohacking.

Metabolic: CMP, fasting glucose, fasting insulin, HbA1c, lipid panel. Hormonal: Total/free testosterone, estradiol, DHEA-S, IGF-1, TSH, free T3/T4. Inflammatory: hs-CRP, homocysteine. Hematology: CBC. Organ: AST, ALT, GGT, BUN, creatinine, eGFR. Nutritional: Vitamin D, B12, folate, iron/ferritin, RBC magnesium.

Get baseline before starting any protocol, then every 90 days.

IGF-1 is produced by the liver in response to GH. Because GH is pulsatile with a short half-life, IGF-1 serves as a stable proxy for overall GH status.

Target: upper third of age-adjusted reference range. Above range = reduce dose. Chronically elevated IGF-1 has been associated with increased cancer risk.

"Normal" ranges represent 95% of the population — which isn't necessarily optimal. Example: Vitamin D lab normal 30-100, optimal target 50-80. Fasting insulin normal up to 25, optimal under 5-7.

Blood work is data input, not diagnosis. Use optimal ranges as targets while understanding they're still debated.

Baseline: Before any protocol. 6-8 weeks: After starting GH peptides (check IGF-1). Every 90 days: Standard cadence for active protocols. Annually: Minimum for general health optimization.

Direct-to-consumer: Marek Health (biohacker panels + physician consultation), InsideTracker (AI analysis), SiPhox Health (at-home testing). Also Quest/LabCorp via discount services.

Ensure panels include: IGF-1, fasting insulin, free T3, hs-CRP, and full hormonal panel — standard "wellness panels" often miss these.

GH peptides: IGF-1, fasting glucose/insulin, HbA1c. GLP-1s: HbA1c, glucose, lipids, amylase/lipase, thyroid, kidneys. Healing: CMP, CBC, hs-CRP. Immune: CBC with differential, T-cell subsets. Longevity: Telomere length, metabolic panel, biological age testing.

1. Get baseline blood work. 2. Start lowest effective dose. 3. Source quality (COA ≥98% HPLC, endotoxin testing). 4. Sterile technique always. 5. Monitor blood work every 90 days. 6. One variable at a time. 7. Listen to your body. 8. Consult a healthcare professional.

Red flags: No COA, HPLC below 95%, no endotoxin testing, discolored powder, no batch numbers, extremely low prices, medical claims, no cold shipping.

Green flags: Batch-specific COA, ≥98% HPLC, mass spectrometry, endotoxin <5 EU/mg, third-party testing, cold-chain shipping.

Mild (injection redness, headache, water retention): Reduce dose 50%, see if symptoms resolve.

Moderate (persistent nausea, significant retention, mood changes): Pause 3-5 days. Restart at 50% or discontinue.

Serious (allergic reaction, breathing difficulty, chest tightness): Discontinue immediately. Seek medical attention.

Caution/contraindication: Active cancer or recent cancer history (growth factor peptides). Pregnant/breastfeeding. Children. Severe kidney/liver disease. Blood thinner users (angiogenesis peptides). Active autoimmune conditions.

Never reuse needles. Use a sharps container (puncture-resistant, leak-proof). Dispose at pharmacies, community drop-off sites, or mail-back programs.

Never throw loose needles in regular trash or recycling.

Tolerance: Yes, with chronic uninterrupted GH secretagogue use. Cycling (5 on/2 off) prevents desensitization.

Physical dependency: Unlikely — peptides signal natural production rather than replacing it.

Psychological dependency: More relevant concern. Maintain fundamentals (sleep, nutrition, exercise) as the foundation.

1. Education (read Protocol Guide). 2. Baseline blood work. 3. Start with ONE peptide (BPC-157 or CJC-1295+Ipamorelin). 4. Source quality. 5. Practice reconstitution carefully. 6. Start at lowest dose for 1-2 weeks. 7. Track everything. 8. Follow-up blood work at 6-8 weeks.

Master the fundamentals first. No peptide compensates for poor sleep, bad nutrition, or no exercise.

Tier 1 (Foundation): 7-9 hours sleep, whole-food nutrition, resistance + cardio training, stress management, social connections.

Tier 2 (Optimization): Blood work tracking, targeted supplements, cold/heat exposure, red light therapy, circadian optimization.

Tier 3 (Advanced): Peptide protocols, longevity interventions, biological age testing.

Most people skip to Tier 3 while neglecting Tier 1. The ROI of fixing sleep almost always exceeds adding a peptide to a broken foundation.